Microbiological profiles in periprosthetic joint infections after total knee arthroplasty: a comparative analysis of diabetic and non-diabetic patients.
Diabetes Mellitus
Knee Arthroplasty
Microbial Diversity
Pathogen Prevalence
Periprosthetic Joint Infection
Journal
International orthopaedics
ISSN: 1432-5195
Titre abrégé: Int Orthop
Pays: Germany
ID NLM: 7705431
Informations de publication
Date de publication:
24 Aug 2024
24 Aug 2024
Historique:
received:
24
04
2024
accepted:
10
08
2024
medline:
24
8
2024
pubmed:
24
8
2024
entrez:
24
8
2024
Statut:
aheadofprint
Résumé
The purpose of this study is to conduct a comparative analysis of the microbiological profiles in periprosthetic joint infections (PJIs) after total knee arthroplasty (TKA) between diabetic and non-diabetic patients. The study aims to address what are the variations in microbial colonization and infection patterns between diabetic and non-diabetic patients undergoing total knee arthroplasty. A retrospective analysis of 2,569 culture-positive cases of PJIs post-TKA was conducted, comparing outcomes between diabetic (n = 321) and non-diabetic (n = 2,248) patients. Demographic, clinical, and microbiological data were collected and analyzed using descriptive statistics, chi-squared tests, logistic regression, and other statistical tests. Diabetic patients exhibited distinct microbial colonization patterns, with a higher prevalence of pathogens such as Staphylococcus aureus (p = 0.033), Pseudomonas aeruginosa (p < 0.001), Streptococcus spp. (Streptococcus agalactiae and Streptococcus dysgalactiae; p = 0.010, 0.016 respectively), Candida spp. (p = 0.010), and Corynebacterium spp. (p = 0.024). Additionally, diabetic patients were at increased risk of polymicrobial infections. Comorbidities associated with diabetes, including chronic pulmonary disease, renal insufficiency, and peripheral artery disease, were significantly more prevalent in diabetic patients and further complicated PJI outcomes. This study underscores the importance of tailored perioperative antimicrobial strategies and vigilant infection control measures in diabetic patients undergoing TKA. Understanding the differential microbial profiles and associated comorbidities can inform targeted interventions to mitigate the risk of PJIs and improve outcomes in this high-risk population. Further research is warranted to elucidate the underlying mechanisms and optimize management strategies for diabetic patients undergoing TKA.
Identifiants
pubmed: 39180538
doi: 10.1007/s00264-024-06275-5
pii: 10.1007/s00264-024-06275-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s) under exclusive licence to SICOT aisbl.
Références
Mistry JB, Elmallah RD, Bhave A, Chughtai M, Cherian JJ, McGinn T, Harwin SF, Mont MAJTjoks (2016) Rehabilitative guidelines after total knee arthroplasty: a review 201–217
Neuprez A, Neuprez AH, Kaux J-F, Kurth W, Daniel C, Thirion T, Huskin J-P, Gillet P, Bruyère O, Reginster J-YJC (2020) Total joint replacement improves pain, functional quality of life, and health utilities in patients with late-stage knee and hip osteoarthritis for up to 5 years 39:861–871
Hernández-Vaquero D, Fernández-Fairen M, Torres A, Menzie AM, Fernández-Carreira JM, Murcia-Mazon A, Guerado E, Merzthal LJTSWJ (2013) Treatment of periprosthetic infections: an economic analysis. 2013
Iannotti F, Prati P, Fidanza A, Iorio R, Ferretti A, Pèrez Prieto D, Kort N, Violante B, Pipino G (2020) Schiavone Panni AJTm, disease i Prevention of periprosthetic joint infection (PJI): a clinical practice protocol in high-risk patients 5:186
Blanco JF, Diaz A, Melchor FR, da Casa C, Pescador DJAO (2020) surgery T Risk factors for periprosthetic joint infection after total knee arthroplasty 140:239–245
Rodriguez-Merchan EC, Delgado-Martinez ADJJCM (2022) Risk factors for periprosthetic joint infection after primary total knee arthroplasty 11:6128
Alamanda VK, Springer BDJC (2018) Perioperative and modifiable risk factors for periprosthetic joint infections (PJI) and recommended guidelines 11:325–331
Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD (2016) one ITJP Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis 11:e0150866
Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CGJCO, Research
Lepetit C, Le Gal S, Michon J, Collon S, Tillou XJI (2015) Pseudomonas aeruginosa septic trapezo-metacarpal arthritis after prostate laser vaporization 43:503–505
Veltman ES, Vos FJ, Meis JF, Goosen JHJJI (2015) Debridement, antibiotics and implant retention in early postoperative infection with Pseudomonas aeruginosa 70:307–309
Zmistowski B, Fedorka CJ, Sheehan E, Deirmengian G, Austin MS, Parvizi JJTJ (2011) Prosthetic joint infection caused by gram-negative organisms 26:104–108
Seyman D, Ozen NS, Inan D, Ongut G, Ogunc DJN (2012) Pseudomonas aeruginosa septic arthritis of knee after intra-articular ozone injection 35:345–348
Shah NB, Osmon DR, Steckelberg JM, Sierra RJ, Walker RC, Tande AJ, Berbari EFJJB, Infection J (2016) Pseudomonas prosthetic joint infections: a review of 102 episodes 1:25–30
Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar KJF (2020) The effects of type 2 diabetes mellitus on organ metabolism and the immune system 11:546198
Pastar I, Ojeh N, Glinos GD, Stojadinovic O, Tomic-Canic MJTDFM, Management S (2018) Physiology and pathophysiology of wound healing in diabetes 109–130
Barrigah-Benissan K, Ory J, Dunyach-Remy C, Pouget C, Lavigne J-P, Sotto AJIJMS (2022) Antibiofilm properties of antiseptic agents used on Pseudomonas aeruginosa isolated from diabetic foot ulcers 23:11270
Zimmerli W, Trampuz A, Ochsner PEJNE (2004) Prosthetic-joint infections 351:1645–1654
Uzun E, Misir A, Ozcamdalli M, Kizkapan EE, Cirakli A, Calgin MKJKS, Sports Traumatology A (2020) Time-dependent surgical instrument contamination begins earlier in the uncovered table than in the covered Table 28:1774–1779
Siu K, Ng F, Chan P, Fu HC, Yan C, Chiu KJHKMJ (2018) Bacteriology and risk factors associated with periprosthetic joint infection after primary total knee arthroplasty: retrospective study of 2543 cases
Weintrob AC, Sexton DJU, edWeller PF, UpToDate, Waltham MA (2016) Susceptibility to infections in persons with diabetes mellitus
Tateiwa T, Ishida T, Takahashi Y, Shinozaki T, Masaoka T, Shishido T, Nishida J, Yamamoto KJJOS (2022) Risk factors for preoperative nasal carriage of methicillin-resistant bacteria in total hip and knee arthroplasty patients 27:798–803
Hansen M-LU, Gotland N, Mejer N, Petersen A, Larsen AR, Benfield T, Diseases DSBSGJI (2017) Diabetes increases the risk of disease and death due to Staphylococcus aureus bacteremia. A matched case-control and cohort study 49:689–697
Zimmerli W, PJA Sendi P (2017) Orthopaedic biofilm infections 125:353–364
Gupta S, Koirala J, Khardori R, Khardori NJINA (2007) Infections in diabetes mellitus and hyperglycemia 21:617–638
Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AWJCid (2012) 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections 54:e132-e173
Mahieu R, Dubée V, Seegers V, Lemarié C, Ansart S, Bernard L, Le Moal G, Asseray N, Arvieux C, Ramanantsoa CJIJID (2019) The prognosis of streptococcal prosthetic bone and joint infections depends on surgical management—a multicenter retrospective study 85:175–181
Stappers MH, Hagen F, Reimnitz P, Mouton JW, Meis JF, Gyssens ICJEJCM, Diseases I (2015) Direct molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infections 34:1885–1892
Rodríguez-Rodríguez N, Martínez-Jiménez I, García-Ojalvo A, Mendoza-Mari Y, Guillén-Nieto G, Armstrong DG (2022) Wound chronicity, impaired immunity and infection in diabetic patients 24:44–58 Berlanga-Acosta JJMr
Marculescu CE, Cantey JRJC (2008) research r Polymicrobial prosthetic joint infections: risk factors and outcome 466:1397–1404
Valenzuela MM, Averkamp BJ, Odum SM, Rowe TM, Fehring TKJTJA (2022) Polymicrobial colonization of prosthetic joint infections treated with open wound management 37:S653–S656
Pereira SG, Moura J, Carvalho E, Empadinhas NJF (2017) Microbiota of chronic diabetic wounds: ecology, impact, and potential for innovative treatment strategies 8:296236
Wimmer MD, Friedrich MJ, Randau TM, Ploeger MM, Schmolders J, Strauss AA, Hischebeth GT, Pennekamp PH, Vavken P, Gravius SJIo (2016) Polymicrobial infections reduce the cure rate in prosthetic joint infections: outcome analysis with two-stage exchange and follow-up ≥ two years 40:1367–1373
Bozhkova S, Tikhilov R, Denisov A, Labutin D, Artiukh V (2015) Polymicrobial etiology of prosthetic joint infections (PJI) as a risk factor of treatment failure after the revision surgery. In: Orthopaedic Proceedings. Bone & Joint. pp. 8–8
Tan TL, Kheir MM, Tan DD, Parvizi JJJ (2016) Polymicrobial periprosthetic joint infections: outcome of treatment and identification of risk factors 98:2082–2088
Belazi M, Velegraki A, Fleva A, Gidarakou I, Papanaum L, Baka D, Daniilidou N, Karamitsos DJM (2005) Candidal overgrowth in diabetic patients: potential predisposing factors 48:192–196
Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate EJC (2017) Chronic complications of diabetes mellitus: a mini review 13:3–10
Nobile CJ, Johnson ADJA (2015) Candida albicans biofilms and human disease 69:71–92
Gross CE, Della Valle CJ, Rex JC, Traven SA, Durante ECJTJA (2021) Fungal periprosthetic joint infection: a review of demographics and management 36:1758–1764
Rudy MD, Ahuja NK, Aaronson AJJJ (2018) Diabetes and hyperglycemia in lower-extremity total joint arthroplasty: clinical epidemiology, outcomes, and management 6:e10
Fisher DA, Dierckman B, Watts MJTJ (2007) Looks good but feels bad: factors that contribute to poor results after total knee arthroplasty 22:306
Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MPJJ (2009) The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty 91:1621–1629
Hwang JS, Kim SJ, Bamne AB, Na YG, Kim TKJCO, Research
Stryker LS, Abdel MP, Morrey ME, Morrow MM, Kor DJ, Morrey BFJJ (2013) Elevated postoperative blood glucose and preoperative hemoglobin A1C are associated with increased wound complications following total joint arthroplasty 95:808–814
Jämsen E, Nevalainen P, Kalliovalkama J, Moilanen TJE (2010) Preoperative hyperglycemia predicts infected total knee replacement 21:196–201
Shohat N, Muhsen K, Gilat R, Rondon AJ, Chen AF, Parvizi JJTJA (2018) Inadequate glycemic control is associated with increased surgical site infection in total joint arthroplasty: a systematic review and meta-analysis 33:2312–2321 e2313
Yang L, Sun Y, Li G, Liu JJM (2017) Is hemoglobin A1c and perioperative hyperglycemia predictive of periprosthetic joint infection following total joint arthroplasty? A systematic review and meta-analysis 96:e8805
Harris AH, Bowe TR, Gupta S, Ellerbe LS, Giori NJJTJ (2013) Hemoglobin A1C as a marker for surgical risk in diabetic patients undergoing total joint arthroplasty 28:25–29
Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WLJTJ (2012) Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection 27:726–729 e721
Baek S-HJW (2014) Identification and preoperative optimization of risk factors to prevent periprosthetic joint infection 5:362
Tarabichi M, Shohat N, Kheir MM, Adelani M, Brigati D, Kearns SM, Patel P, Clohisy JC, Higuera CA, Levine BRJTJ (2017) Determining the threshold for HbA1c as a predictor for adverse outcomes after total joint arthroplasty: a multicenter, retrospective study 32:S263–S267 e261